Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168390456> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2168390456 endingPage "16" @default.
- W2168390456 startingPage "11" @default.
- W2168390456 abstract "Several agents have been tried in the management of mastalgia. Centchroman (Ormeloxifene), a novel non-steroidal selective estrogen receptor modulator (SERM), has also been recently used in the management of mastalgia. Eligible patients, who had mastalgia for more than 3 months, were randomized into two groups – Group A received centchroman 30 mg daily and Group B received tamoxifen 10 mg daily. Treatment was continued for a total of 12 weeks; thereafter, patients were followed for another 12 weeks without medication to assess the continuum of relief. Pain severity was measured with VAS score. Patients were considered to have complete pain relief if their VAS score decreased to 3 or less. Patients, in both the groups, showed gradual improvement in mastalgia with passage of time up to 12 weeks. Following cessation of treatment at 12 weeks, partial relapse of pain was observed at 24 weeks. There was no significant difference between Group A and Group B in terms of mean VAS Score and proportion of women reporting pain relief at 4, 8, 12, and 24 weeks. Fifteen patients in Group A had side effects namely dizziness, menstrual irregularities and development of ovarian cysts. There was no side effect noted in group B. Centchroman and tamoxifen were found to be of similar effectiveness in providing pain relief in mastalgia. High frequency of side effects, particularly development of ovarian cyst, in patients receiving centchroman is a matter of concern." @default.
- W2168390456 created "2016-06-24" @default.
- W2168390456 creator A5004438127 @default.
- W2168390456 creator A5034454825 @default.
- W2168390456 creator A5052521183 @default.
- W2168390456 creator A5056920787 @default.
- W2168390456 creator A5070708890 @default.
- W2168390456 date "2015-03-01" @default.
- W2168390456 modified "2023-09-30" @default.
- W2168390456 title "Centchroman vs tamoxifen for regression of mastalgia: A randomized controlled trial" @default.
- W2168390456 cites W1619038121 @default.
- W2168390456 cites W1973974063 @default.
- W2168390456 cites W2007593622 @default.
- W2168390456 cites W2058824942 @default.
- W2168390456 cites W2063316507 @default.
- W2168390456 cites W2170259506 @default.
- W2168390456 doi "https://doi.org/10.1016/j.ijsu.2014.12.033" @default.
- W2168390456 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25619124" @default.
- W2168390456 hasPublicationYear "2015" @default.
- W2168390456 type Work @default.
- W2168390456 sameAs 2168390456 @default.
- W2168390456 citedByCount "16" @default.
- W2168390456 countsByYear W21683904562016 @default.
- W2168390456 countsByYear W21683904562017 @default.
- W2168390456 countsByYear W21683904562018 @default.
- W2168390456 countsByYear W21683904562019 @default.
- W2168390456 countsByYear W21683904562020 @default.
- W2168390456 countsByYear W21683904562021 @default.
- W2168390456 countsByYear W21683904562022 @default.
- W2168390456 crossrefType "journal-article" @default.
- W2168390456 hasAuthorship W2168390456A5004438127 @default.
- W2168390456 hasAuthorship W2168390456A5034454825 @default.
- W2168390456 hasAuthorship W2168390456A5052521183 @default.
- W2168390456 hasAuthorship W2168390456A5056920787 @default.
- W2168390456 hasAuthorship W2168390456A5070708890 @default.
- W2168390456 hasBestOaLocation W21683904561 @default.
- W2168390456 hasConcept C121608353 @default.
- W2168390456 hasConcept C126322002 @default.
- W2168390456 hasConcept C168563851 @default.
- W2168390456 hasConcept C2777176818 @default.
- W2168390456 hasConcept C2777785397 @default.
- W2168390456 hasConcept C2777944059 @default.
- W2168390456 hasConcept C2780932660 @default.
- W2168390456 hasConcept C29456083 @default.
- W2168390456 hasConcept C2992669165 @default.
- W2168390456 hasConcept C42219234 @default.
- W2168390456 hasConcept C530470458 @default.
- W2168390456 hasConcept C71924100 @default.
- W2168390456 hasConceptScore W2168390456C121608353 @default.
- W2168390456 hasConceptScore W2168390456C126322002 @default.
- W2168390456 hasConceptScore W2168390456C168563851 @default.
- W2168390456 hasConceptScore W2168390456C2777176818 @default.
- W2168390456 hasConceptScore W2168390456C2777785397 @default.
- W2168390456 hasConceptScore W2168390456C2777944059 @default.
- W2168390456 hasConceptScore W2168390456C2780932660 @default.
- W2168390456 hasConceptScore W2168390456C29456083 @default.
- W2168390456 hasConceptScore W2168390456C2992669165 @default.
- W2168390456 hasConceptScore W2168390456C42219234 @default.
- W2168390456 hasConceptScore W2168390456C530470458 @default.
- W2168390456 hasConceptScore W2168390456C71924100 @default.
- W2168390456 hasFunder F4320324131 @default.
- W2168390456 hasLocation W21683904561 @default.
- W2168390456 hasLocation W21683904562 @default.
- W2168390456 hasOpenAccess W2168390456 @default.
- W2168390456 hasPrimaryLocation W21683904561 @default.
- W2168390456 hasRelatedWork W145065296 @default.
- W2168390456 hasRelatedWork W1799437221 @default.
- W2168390456 hasRelatedWork W2061974211 @default.
- W2168390456 hasRelatedWork W2071258892 @default.
- W2168390456 hasRelatedWork W2110184485 @default.
- W2168390456 hasRelatedWork W2168390456 @default.
- W2168390456 hasRelatedWork W2308159857 @default.
- W2168390456 hasRelatedWork W2501535603 @default.
- W2168390456 hasRelatedWork W4233971991 @default.
- W2168390456 hasRelatedWork W2182070429 @default.
- W2168390456 hasVolume "15" @default.
- W2168390456 isParatext "false" @default.
- W2168390456 isRetracted "false" @default.
- W2168390456 magId "2168390456" @default.
- W2168390456 workType "article" @default.